Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide

被引：24
|
作者：
Trapella, Claudio [1 ,2 ]
Fischetti, Carmela [3 ,4 ,5 ]
Pela', Michela [1 ,2 ]
Lazzari, Ilaria [1 ,2 ]
Guerrini, Remo [1 ,2 ]
Calo', Girolamo [3 ,4 ]
Rizzi, Anna [3 ,4 ]
Camarda, Valeria [3 ,4 ]
Lambert, David G. [5 ]
McDonald, John [5 ]
Regoli, Domenico [3 ,4 ]
Salvadori, Severo [1 ,2 ]
机构：
[1] Univ Ferrara, Dept Pharmaceut Sci, I-44100 Ferrara, Italy
[2] Univ Ferrara, Ctr Biotechnol, I-44100 Ferrara, Italy
[3] Univ Ferrara, Pharmacol Sect, Dept Expt & Clin Med, I-44100 Ferrara, Italy
[4] Univ Ferrara, Natl Inst Neurosci, I-44100 Ferrara, Italy
[5] Univ Leicester, Leicester Royal Infirm,Pharmacol & Therapeut Grp, Dept Cardiovasc Sci, Div Anaesthesia Crit Care & Pain Management, Leicester LE1 5WW, Leics, England
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2009年 / 17卷 / 14期
关键词：
SAR studies; NOP receptor antagonists; Receptor and [S-35]GTP gamma S binding; Mouse vas deferens; Calcium mobilization; Tail withdrawal assay; PHARMACOLOGICAL CHARACTERIZATION; IN-VITRO; AGONIST; POTENT; UFP-101; PROFILE; ORL1;
D O I：
10.1016/j.bmc.2009.05.068
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Twelve derivatives of the nociceptin/orphanin FQ (N/OFQ) receptor (NOP) antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide (Comp 24) were synthesised and tested in binding experiments performed on CHOhNOP cell membranes. Among them, a novel interesting NOP receptor antagonist (compound 35) was identified by blending chemical moieties taken from different NOP receptor ligands. In vitro in various assays, Compound 35 consistently behaved as a pure, highly potent (pA(2) in the range 8.0-9.9), competitive and NOP selective antagonist. However compound 35 was found inactive when challenged against N/OFQ in vivo in the mouse tail withdrawal assay. Thus the usefulness of the novel NOP ligand compound 35 is limited to in vitro investigations. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码：5080 / 5095
页数：16
相关论文
共 50 条
  • [31] Efficient design, synthesis and structure-activity relationship studies of 1-(3′-substituted propyl)-4-arylpiperidines as non-peptide antagonists of nociceptin/orphanin FQ receptor: biological activities, metabolic stabilities and hERG channel bindings
    Hayashi, Shigeo
    Ohashi, Katsuyo
    Nakata, Eriko
    Emoto, Chie
    MEDICINAL CHEMISTRY RESEARCH, 2014, 23 (01) : 526 - 552
  • [32] Sterically shielded pyrrolidine nitroxides with 3-(4,5-dicarboxy-1H-1,2,3-triazol-1-yl)propyl substituent
    Trakhinina, S. Yu.
    Taratayko, A. I.
    Glazachev, Yu. I.
    Kirilyuk, I. A.
    RUSSIAN CHEMICAL BULLETIN, 2023, 72 (07) : 1569 - 1575
  • [33] Sterically shielded pyrrolidine nitroxides with 3-(4,5-dicarboxy-1H-1,2,3-triazol-1-yl)propyl substituent
    S. Yu. Trakhinina
    A. I. Taratayko
    Yu. I. Glazachev
    I. A. Kirilyuk
    Russian Chemical Bulletin, 2023, 72 : 1569 - 1575
  • [34] Identification and structure-activity relationships of 1-aryl-3-piperidin-4-yl-urea derivatives as CXCR3 receptor antagonists
    Allen, Daniel R.
    Bolt, Amanda
    Chapman, Gayle A.
    Knight, Roland L.
    Meissner, Johannes W. G.
    Owen, David A.
    Watson, Robert J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (03) : 697 - 701
  • [35] Synthesis and anti-inflammatory activity of some novel 3-phenyl-N-[3-(4-phenylpiperazin-1yl)propyl]-1H-pyrazole-5-carboxamide derivatives
    Nagarapu, Lingaiah
    Mateti, Jhansi
    Gaikwad, Hanmant K.
    Bantu, Rajashaker
    Rani, M. Sheeba
    Subhashini, N. J. Prameela
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (14) : 4138 - 4140
  • [36] Synthesis and antimicrobial activity of 1-benzhydryl-sulfonyl-4-(3-(piperidin-4-yl) propyl)piperidine derivatives against pathogens of Lycopersicon esculentum: A structure-activity evaluation study
    K. Vinaya
    R. Kavitha
    C. S. Ananda Kumar
    S. B. Benaka Prasad
    S. Chandrappa
    S. A. Deepak
    S. Nanjunda Swamy
    S. Umesha
    K. S. Rangappa
    Archives of Pharmacal Research, 2009, 32 : 33 - 41
  • [37] Synthesis and antimicrobial activity of 1-benzhydryl-sulfonyl-4-(3-(piperidin-4-yl) propyl)piperidine derivatives against pathogens of Lycopersicon esculentum: A structure-activity evaluation study
    Vinaya, K.
    Kavitha, R.
    Kumar, C. S. Ananda
    Prasad, S. B. Benaka
    Chandrappa, S.
    Deepak, S. A.
    Swamy, S. Nanjunda
    Umesha, S.
    Rangappa, K. S.
    ARCHIVES OF PHARMACAL RESEARCH, 2009, 32 (01) : 33 - 41
  • [38] Discovery, Structure-Activity Relationship, and Mechanistic Studies of 1-((3R,4S)-3-((Dimethylamino)methyl)-4-hydroxy-4-(3-methoxyphenyl)piperidin-1-yl)-2-(2,4,5-trifluorophenyl)ethan-1-one as a Novel Potent Analgesic
    Huang, Huoming
    Li, Xueping
    Xie, Peng
    Li, Xinwei
    Xu, XueJun
    Qian, Yuanyuan
    Yuan, Congmin
    Meng, Xiangguo
    Chai, JingRui
    Chen, Jing
    Liu, Jing
    Wang, Wenli
    Li, Wei
    Wang, YuJun
    Fu, Wei
    Liu, Jinggen
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (13) : 9458 - 9483
  • [39] (R)-3,N-dimethyl-N-[1-methyl-3-(4-methyl-piperidin-1-yl)propyl]benzenesulfonamide:: The first selective 5-HT7 receptor antagonist
    Forbes, IT
    Dabbs, S
    Duckworth, DM
    Jennings, AJ
    King, FD
    Lovell, PJ
    Brown, AM
    Collin, L
    Hagan, JJ
    Middlemiss, DN
    Riley, GJ
    Thomas, DR
    Upton, N
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (05) : 655 - 657
  • [40] Synthesis and structure-activity relationships of 2-(substituted phenyl)-3-[3-(N,N-dimethylamino)propyl]-1,3-thiazolidin-4-ones acting as H1-histamine antagonists
    Diurno, MV
    Mazzoni, O
    Correale, G
    Monterrey, IG
    Calignano, A
    La Rana, G
    Bolognese, A
    FARMACO, 1999, 54 (09): : 579 - 583
12345